Is clinical trial representation fair? Learn why disease incidence matters more than Census data for health equity.
In a small Phase II trial, people with cocaine use disorder who took mavoglurant used the drug less often over a three month ...
Ethan Grimes, BS, and Paul Morgan, MD, conduct rational drug design at the newly launched AI Small Molecule Drug Discovery Center at the Icahn School of Medicine at Mount Sinai. As part of Mount Sinai ...
Three other Bay Area companies — Mirum Therapeutics Inc. (Nasdaq: MIRM), Soleno Therapeutics Inc. (Nasdaq: SLNO) and Exelixis ...
The Hatch Waxman Act and the Biological Price Competition and Innovation Act have incentivized efforts to improperly prolong ...
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...
Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ...
The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...
The ouster of Peter Marks, the FDA official who oversaw vaccines, gene therapies, and the blood supply, has alarmed biopharma ...